Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition.

Lamouille S, Derynck R.

Cells Tissues Organs. 2011;193(1-2):8-22. doi: 10.1159/000320172. Epub 2010 Nov 2. Review.

2.
3.

TGF-β signaling and epithelial-mesenchymal transition in cancer progression.

Katsuno Y, Lamouille S, Derynck R.

Curr Opin Oncol. 2013 Jan;25(1):76-84. doi: 10.1097/CCO.0b013e32835b6371. Review.

PMID:
23197193
4.

Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition.

Derynck R, Muthusamy BP, Saeteurn KY.

Curr Opin Cell Biol. 2014 Dec;31:56-66. doi: 10.1016/j.ceb.2014.09.001. Epub 2014 Sep 18. Review.

5.
6.

A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition.

Xu W, Yang Z, Lu N.

Cell Adh Migr. 2015;9(4):317-24. doi: 10.1080/19336918.2015.1016686. Epub 2015 Aug 4. Review.

7.

Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer.

Zhang L, Zhou F, ten Dijke P.

Trends Biochem Sci. 2013 Dec;38(12):612-20. doi: 10.1016/j.tibs.2013.10.001. Epub 2013 Nov 14. Review.

PMID:
24239264
8.

Transcriptional and post-transcriptional regulation in TGF-β-mediated epithelial-mesenchymal transition.

Saitoh M, Miyazawa K.

J Biochem. 2012 Jun;151(6):563-71. doi: 10.1093/jb/mvs040. Epub 2012 Apr 23. Review.

PMID:
22528665
9.
10.

Epithelial-mesenchymal Transition and Cell Invasion.

Son H, Moon A.

Toxicol Res. 2010 Dec;26(4):245-52. doi: 10.5487/TR.2010.26.4.245. Review.

11.

[The TGF-β signaling pathway induced EMT in breast cancer].

Ma Y, Liu H, Zhang H, Shao RG.

Yao Xue Xue Bao. 2015 Apr;50(4):385-92. Review. Chinese.

PMID:
26223118
12.

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.

Chang L, Graham PH, Hao J, Bucci J, Cozzi PJ, Kearsley JH, Li Y.

Cancer Metastasis Rev. 2014 Sep;33(2-3):469-96. doi: 10.1007/s10555-014-9493-5. Review.

PMID:
24445654
13.

Transcriptional crosstalk between TGF-β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes.

Fuxe J, Vincent T, Garcia de Herreros A.

Cell Cycle. 2010 Jun 15;9(12):2363-74. Epub 2010 Jun 15. Review.

PMID:
20519943
14.

[Advances of transforming growth factor-β inhibitors].

Ge XX, Zhou QF, Chen GL.

Yao Xue Xue Bao. 2015 Apr;50(4):413-8. Review. Chinese.

PMID:
26223122
15.

Biomechanics of TGFβ-induced epithelial-mesenchymal transition: implications for fibrosis and cancer.

O'Connor JW, Gomez EW.

Clin Transl Med. 2014 Jul 15;3:23. doi: 10.1186/2001-1326-3-23. eCollection 2014. Review.

16.

Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon.

Sipos F, Galamb O.

World J Gastroenterol. 2012 Feb 21;18(7):601-8. doi: 10.3748/wjg.v18.i7.601. Review.

17.

Regulation of the TGF-β pathway by deubiquitinases in cancer.

Liu S, de Boeck M, van Dam H, Ten Dijke P.

Int J Biochem Cell Biol. 2016 Jul;76:135-45. doi: 10.1016/j.biocel.2016.05.001. Epub 2016 May 4. Review.

PMID:
27155333
18.

[Mechanism of and Therapy for Kidney Fibrosis].

Kuma A, Tamura M, Otsuji Y.

J UOEH. 2016 Mar 1;38(1):25-34. doi: 10.7888/juoeh.38.25. Review. Japanese.

19.

Interplay of retinal determination gene network with TGF-β signaling pathway in epithelial-mesenchymal transition.

Liu Y, Kong D, Wu H, Yuan X, Xu H, Zhang C, Wu G, Wu K.

Stem Cell Investig. 2015 Jun 9;2:12. doi: 10.3978/j.issn.2306-9759.2015.05.03. eCollection 2015. Review.

20.

The route to personalized medicine in bladder cancer: where do we stand?

Massari F, Ciccarese C, Santoni M, Brunelli M, Conti A, Modena A, Montironi R, Santini D, Cheng L, Martignoni G, Cascinu S, Tortora G.

Target Oncol. 2015 Sep;10(3):325-36. doi: 10.1007/s11523-015-0357-x. Epub 2015 Jan 30. Review.

PMID:
25634607
Items per page

Supplemental Content

Write to the Help Desk